Atlas Trials

Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

Clinical trial NCT00979745 · COMPLETED

Trial details

NCT number
NCT00979745
Sponsor
Clinuvel Pharmaceuticals Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Erythropoietic Protoporphyria
Start date
2009-09-01
Primary completion
2011-05-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.